Concert to seek approval for hair loss drug after second study success
Bio Pharma Dive
AUGUST 1, 2022
The biotech plans to file an application with the FDA in the first half of next year for clearance in alopecia areata, potentially positioning it to compete with Eli Lilly and Pfizer for market share.
Let's personalize your content